| | | | | | |

Cholesterol Drug May Protect Mesothelioma Patients from Radiation

ByAlex Strauss

A new study suggests that the cholesterol-lowering drug pravastatin could one-day be used to help protect mesothelioma patients from the damaging side effects of radiotherapy.

According to Japanese researchers, mice with malignant mesothelioma who were given pravastatin (Pravachol) in drinking water prior to receiving radiation experienced less damage to healthy cells in their lungs and intestines.

The results suggest that pravastatin might make radiotherapy safer and more effective for people with pleural or peritoneal mesothelioma and other cancers.

How Does Pravastatin Work?

Like other statin drugs, pravastatin is designed to lower the level of low-density lipoprotein (LDL) or “bad” cholesterol in the blood while increasing levels of “good” cholesterol or high-density lipoprotein (HDL).

Marketed under the brand name Pravachol, pravastatin is used to help prevent heart attacks and strokes in high risk patients but it has also been reported to have therapeutic applications in a range of inflammatory conditions.

Radiotherapy and Mesothelioma

Radiotherapy is one of treatments doctors utilize to treat mesothelioma and many other cancers. In conjunction with chemotherapy and surgery, radiotherapy may extend survival by disrupting the DNA of cancer cells, making it harder for them to replicate and grow out of control.

Side effects occur when radiation is absorbed by healthy tissues. In people with mesothelioma, the location and irregular shape of their tumors often makes it difficult to irradiate them without also irradiating some of the surrounding healthy tissue in the lungs or abdomen.

When the DNA of these normal cells is sufficiently damaged, the results can be life-threatening.

Protecting Mesothelioma Patients from Side Effects

In their new study, on the radioprotective effects of pravastatin, researchers at Hyogo College of Medicine treated two groups of lab mice with ionizing radiation.

One group received 30 mg of pravastatin per kg of body weight 24 hours before treatment and again 4 hours before treatment. The second group of mice was not pretreated.

“The pravastatin group showed significantly lower apoptotic indices in all examined parts of the intestine and tended to show reduced apoptosis [cell death] in the lung,” writes radiologist and lead investigator Hiroshi Doi.

Just as importantly, the team found no difference in responsiveness of mesothelioma tumors in the treated and untreated mice, suggesting that pravastatin will not interfere with the effectiveness of radiotherapy in mesothelioma patients.

The authors conclude that pravastatin may “increase the therapeutic index of radiotherapy”, making it possible to treat mesothelioma with fewer serious side effects.

Statins and Mesothelioma

Several previous studies have also highlighted the potential benefits of using statin drugs in mesothelioma treatment. A 2014 study in the International Journal of Oncology suggested that the drug simvastatin may boost the effectiveness of pemetrexed (Alimta) in mesothelioma treatment.

Another Japanese study conducted in 2013 found that combining two statin drugs with gamma-tocotrienol triggered apoptosis in mesothelioma cells.

Source:

Doi, H, et al “Pravastatin reduces radiation-induced damage in normal tissues”, May 2017, Experimental and Therapeutic Medicine, pp. 1765-1772

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…